| Application no. and date | 18779167.8 (espacenet) (Federated) (European Patent Register), 20180910 | | Patent/reg. no. and date | DK/EP 3681483, 20220518 | | Publication date | 20200722 | | Priority no. and date | US 201762559420 P, 20170915 | | EP pub. no. and date |
EP 3681483 20200722 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, California 91320-1799, US | | Applicant ref. no. | 1643877 | | Inventor | TALLEY, Clea, 2621 Paseo Yolo
Camarillo, California 93010, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/19 (2006.01) , A61K 47/10 (2017.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 9/19 (2006.01) | | Title | FREMGANGSMÅDE TIL LYOFILISERET FARMACEUTISK FORMULERING AF ET TERAPEUTISK PROTEIN | | Int. application no. | US2018050305 | | Int. publication no. | WO2019055357 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
